Amedeo Smart

Free Medical Literature Service


 

Amedeo

Rheumatoid Arthritis

  Free Subscription

Articles published in
Scand J Rheumatol
    September 2025
  1. IKDAHL E, Mangseth H
    Are we screening effectively? A systematic review and meta-analysis of proposed risk factors for rheumatoid arthritis-associated interstitial lung disease screening.
    Scand J Rheumatol. 2025 Sep 9:1-9. doi: 10.1080/03009742.2025.2538946.
    >> Share

  2. CHENG L, Jia L, Zhao G, Lin X, et al
    Rheumatoid arthritis complicated by sacroiliac joint infection: a case report.
    Scand J Rheumatol. 2025 Sep 1:1-3. doi: 10.1080/03009742.2025.2540169.
    >> Share

    August 2025
  3. TAN YK, Conaghan PG
    Understanding the use of thermography and its ability to predict ultrasound-detected joint inflammation at the metacarpophalangeal joint in patients with rheumatoid arthritis.
    Scand J Rheumatol. 2025 Aug 29:1-5. doi: 10.1080/03009742.2025.2548061.
    >> Share

  4. SKIELTA M, Soderstrom L, Rantapaa-Dahlqvist S, Sodergren A, et al
    Is there an association between anti-inflammatory medical treatments for rheumatoid arthritis and mortality after first myocardial infarction?
    Scand J Rheumatol. 2025 Aug 29:1-7. doi: 10.1080/03009742.2025.2544409.
    >> Share

  5. REN J, Li R, Peng H
    The relationship between arthritis or rheumatoid arthritis in the elderly and falls: results based on the China Health and Retirement Longitudinal Study (CHARLS).
    Scand J Rheumatol. 2025 Aug 11:1-4. doi: 10.1080/03009742.2025.2518630.
    >> Share

    June 2025
  6. SANDSTROM T, Kaipiainen-Seppanen O, Mali M, Kauppi M, et al
    Limited reduction of bone mineral density in patients with early rheumatoid arthritis receiving aggressive treatment: 10 year results of the NEO-RACo study.
    Scand J Rheumatol. 2025 Jun 23:1-9. doi: 10.1080/03009742.2025.2515696.
    >> Share

  7. KODISHALA C, Jose George R, Javed R, Lovering EJ, et al
    Role of rheumatoid arthritis flare in the risk of Alzheimer's disease and related dementias: a population-based cohort study.
    Scand J Rheumatol. 2025 Jun 3:1-8. doi: 10.1080/03009742.2025.2503055.
    >> Share

  8. HYLDGAARD C, Pedersen AR, Ellingsen T, Bendstrup E, et al
    Pulmonary function trajectories in rheumatoid arthritis-associated interstitial lung disease.
    Scand J Rheumatol. 2025 Jun 3:1-7. doi: 10.1080/03009742.2025.2503054.
    >> Share

    May 2025
  9. LING SF, Ho P, Bukhari M, Mewar D, et al
    Pretreatment absolute monocyte counts are associated with biological disease-modifying anti-rheumatic drug non-response in patients with rheumatoid arthritis.
    Scand J Rheumatol. 2025 May 21:1-6. doi: 10.1080/03009742.2025.2497606.
    >> Share

  10. LI CH, Gao JL, Ren C, Yang SM, et al
    Synovial chondromatosis in a patient with atypical rheumatoid arthritis confirmed by clinical, radiographic, and pathological evidence: a case report.
    Scand J Rheumatol. 2025 May 9:1-3. doi: 10.1080/03009742.2025.2491181.
    >> Share

  11. NANJAIAH H, Moudgil KD
    Pristimerin inhibits the progression of antibody-induced autoimmune arthritis.
    Scand J Rheumatol. 2025;54:198-203.
    >> Share

    April 2025
  12. SAKELLARIOU GT, Chaitidis N, Katsigianni I, Tsifountoudis I, et al
    A patient with multiple sclerosis successfully treated with tofacitinib for rheumatoid arthritis.
    Scand J Rheumatol. 2025 Apr 1:1-3. doi: 10.1080/03009742.2025.2463733.
    >> Share

    March 2025
  13. LAURIDSEN KB, Duch KS, Mortensen AS, Cordtz R, et al
    Sex differences in treatment response in patients with rheumatoid arthritis treated with tumour necrosis factor inhibitor: a cohort study from the DANBIO registry.
    Scand J Rheumatol. 2025 Mar 20:1-11. doi: 10.1080/03009742.2025.2471713.
    >> Share

    February 2025
  14. PEDERSEN SD, Nielsen BD, Assmann ML, Hauge EM, et al
    Early diagnosis of rheumatoid arthritis: associations between patients' perceptions of initial symptoms and the timing of seeking help from the general practitioner.
    Scand J Rheumatol. 2025 Feb 27:1-10. doi: 10.1080/03009742.2025.2464457.
    >> Share

  15. KNUDSEN LR, Knitza J, Muhlensiepen F, Hueber A, et al
    Development and validation of a patient knowledge questionnaire for rheumatoid arthritis (PKQ-RA-11) in Danish and German.
    Scand J Rheumatol. 2025 Feb 24:1-9. doi: 10.1080/03009742.2025.2463734.
    >> Share

  16. NAKAGOMI D, Hanai S
    Rapid improvement of rheumatoid arthritis symptoms with ozoralizumab: a case of progress monitored by musculoskeletal ultrasonography.
    Scand J Rheumatol. 2025 Feb 19:1-2. doi: 10.1080/03009742.2025.2464451.
    >> Share

  17. ACAR EA, Uslu S, Soysal Gunduz O, Pirildar T, et al
    'Pencil-in-cup' deformity in systemic sclerosis-rheumatoid arthritis overlap syndrome.
    Scand J Rheumatol. 2025 Feb 11:1-3. doi: 10.1080/03009742.2025.2456323.
    >> Share

  18. FUKUI S, Tawakol A, Winkelmayer WC, Santacroce LM, et al
    No association between vascular inflammation and estimated glomerular filtration rate in patients with rheumatoid arthritis: secondary analysis of the TARGET trial.
    Scand J Rheumatol. 2025 Feb 5:1-4. doi: 10.1080/03009742.2025.2455878.
    >> Share

  19. BAKKER NF, Knoop J, Schoones JW, Vliet Vlieland T, et al
    Work in the picture? The reporting of and effects on work outcomes in exercise therapy trials in people with rheumatoid arthritis or axial spondyloarthritis: a systematic review.
    Scand J Rheumatol. 2025 Feb 4:1-17. doi: 10.1080/03009742.2024.2445940.
    >> Share

    January 2025
  20. HUPER S, Nagler L, Strunz PP, Froehlich M, et al
    Lymphoma in Sjogren's syndrome: no need for repetitive screening ultrasounds of the major salivary glands and neck in asymptomatic patients.
    Scand J Rheumatol. 2025;54:49-57.
    >> Share

  21. LOFFLER C, Leipe J, Hellmich B
    Ultrasonographic findings in diabetic cheiroarthropathy: a pilot study.
    Scand J Rheumatol. 2025;54:41-48.
    >> Share

  22. JORGENSEN TS, Hansen RL, Pouls B, Van den Bemt B, et al
    Retention rate of a novel autoinjector e-Device introduced to patients with chronic arthritis treated with certolizumab pegol in clinical practice: an observational implementation study.
    Scand J Rheumatol. 2025;54:25-32.
    >> Share

    November 2024
  23. RASMUSSEN C, Can G, Steffensen R, Kenar Artin G, et al
    Incident rheumatoid arthritis in patients living in Turkey and in Denmark: a comparative clinical, genetic, and serological study.
    Scand J Rheumatol. 2024 Nov 25:1-8. doi: 10.1080/03009742.2024.2424083.
    >> Share

  24. LIU T, Wang M, Li L, Wu T, et al
    Mitophagy drives maldifferentiation of tissue-resident memory T cells in patients with rheumatoid arthritis.
    Scand J Rheumatol. 2024 Nov 15:1-10. doi: 10.1080/03009742.2024.2420432.
    >> Share

  25. PALSSON O, Love TJ, Wallman JK, Kapetanovic MC, et al
    Prescription of non-steroidal anti-inflammatory drugs for patients with inflammatory arthritis decreases with the initiation of tumour necrosis factor inhibitor therapy: results from the ICEBIO registry.
    Scand J Rheumatol. 2024;53:402-408.
    >> Share

    October 2024
  26. VAN DEN DIKKENBERG M, Kuijper TM, Kok MR, Lopes Barreto D, et al
    Remote patient-reported outcome measure triage score for monitoring disease activity and allocation of consultations in rheumatoid arthritis patients.
    Scand J Rheumatol. 2024 Oct 30:1-8. doi: 10.1080/03009742.2024.2406611.
    >> Share

  27. COLMENARES V, Hedman A, Hesslow A, Wahlin B, et al
    Cohort study of serological biomarkers for interstitial lung disease in patients with rheumatoid arthritis.
    Scand J Rheumatol. 2024 Oct 25:1-10. doi: 10.1080/03009742.2024.2413238.
    >> Share

  28. HYLDGAARD C, Blegvad J, Sofiudottir BK, Andersen FD, et al
    Risk profiles for rheumatoid arthritis-associated interstitial lung disease in a cohort of patients with five-year follow-up.
    Scand J Rheumatol. 2024 Oct 24:1-6. doi: 10.1080/03009742.2024.2408867.
    >> Share

  29. TEUWEN M, van Weely S, van den Ende C, van Wissen M, et al
    Cost-utility analysis of longstanding exercise therapy versus usual care in people with rheumatoid arthritis and severe functional limitations.
    Scand J Rheumatol. 2024 Oct 1:1-11. doi: 10.1080/03009742.2024.2392360.
    >> Share

    September 2024
  30. ANDERSEN BB, Greisen S, Stengaard-Pedersen K, Junker P, et al
    Plasma haem oxygenase-1 may represent a first-in-class biomarker of oxidative stress in rheumatoid arthritis.
    Scand J Rheumatol. 2024 Sep 17:1-5. doi: 10.1080/03009742.2024.2392364.
    >> Share

  31. TAKATANI A, Kobayashi T, Iwamoto N, Aramaki T, et al
    Methotrexate prolonged the shedding of replicable SARS-CoV-2 with re-increased antigens in a rheumatoid arthritis patient.
    Scand J Rheumatol. 2024 Sep 4:1-3. doi: 10.1080/03009742.2024.2361994.
    >> Share

  32. ZHU F, Zhang Y
    Rheumatoid arthritis with rice bodies bursitis.
    Scand J Rheumatol. 2024;53:359-360.
    >> Share

  33. SOKKA-ISLER T, Paalanen K, Puolakka K
    Keep a closer eye on 'seronegative rheumatoid arthritis'.
    Scand J Rheumatol. 2024;53:293-294.
    >> Share

    August 2024
  34. TICHY S, Nekvindova L, Baranova J, Vencovsky J, et al
    Drug survival analysis of etanercept compared with monoclonal antibody tumour necrosis factor-alpha inhibitors in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a propensity score-matched analysis from the Czech ATTRA registry.
    Scand J Rheumatol. 2024 Aug 6:1-8. doi: 10.1080/03009742.2024.2381746.
    >> Share

    July 2024
  35. EKICI M, Baytar Y, Akdogan A, Durhan G, et al
    Prognostic factors for interstitial lung disease progression in rheumatoid arthritis: May methotrexate protect against progression?
    Scand J Rheumatol. 2024 Jul 25:1-9. doi: 10.1080/03009742.2024.2371658.
    >> Share

  36. SOUSSI BG, Cordtz RL, Duch K, Kristensen S, et al
    Incidence of seropositive and seronegative rheumatoid arthritis in Denmark: a nationwide population-based study.
    Scand J Rheumatol. 2024 Jul 8:1-9. doi: 10.1080/03009742.2024.2365540.
    >> Share

  37. TESTA D, Bilia S, Tavoni AG, Migliorini P, et al
    Adult-onset Still's disease: analysis of a monocentric cohort of patients.
    Scand J Rheumatol. 2024;53:263-268.
    >> Share

  38. AYANO M, Tsubouchi K, Suzuki K, Kimoto Y, et al
    Comparing the safety and efficacy of nintedanib starting dose in patients with connective tissue disease-associated interstitial lung diseases.
    Scand J Rheumatol. 2024;53:255-262.
    >> Share

  39. YOSHIHARA R, Tsuchiya H, Shoda H, Fujio K, et al
    Relationship between earlier introduction of tocilizumab and glucocorticoid-sparing effects on the acute phase of adult-onset Still's disease.
    Scand J Rheumatol. 2024;53:284-287.
    >> Share

    June 2024
  40. FARINA N, Tomelleri A, Boffini N, Cariddi A, et al
    Retention rates of different Janus kinase inhibitors in rheumatoid arthritis: experience from a large monocentric cohort.
    Scand J Rheumatol. 2024 Jun 4:1-5. doi: 10.1080/03009742.2024.2353433.
    >> Share

    May 2024
  41. PROVAN SA, Ahlfors F, Bakland G, Hu Y, et al
    A validation of register-derived diagnoses of interstitial lung disease in patients with inflammatory arthritis: data from the NOR-DMARD study.
    Scand J Rheumatol. 2024;53:173-179.
    >> Share

  42. GERTEL S, Rokach M, Polachek A, Litinsky I, et al
    Anti-inflammatory effects of infliximab and methotrexate on peripheral blood and synovial fluid mononuclear cells: ex vivo study.
    Scand J Rheumatol. 2024;53:188-198.
    >> Share

    April 2024
  43. LI Z, Lei S, Zhou S, Zhang Z, et al
    Rheumatoid arthritis with chylothorax: a case report.
    Scand J Rheumatol. 2024 Apr 30:1-2. doi: 10.1080/03009742.2024.2342053.
    >> Share

    March 2024
  44. AHAMMAR S, Martinsson K, Ziegelasch M, Kastbom A, et al
    Prognostic value of serum protein electrophoresis constituents for arthritis development in anti-citrullinated protein antibody-positive patients with musculoskeletal pain.
    Scand J Rheumatol. 2024;53:118-122.
    >> Share

    February 2024
  45. WANG J, Vordenbaumen S, Schneider M, Brinks R, et al
    Population-based epidemiological projections of rheumatoid arthritis in Germany until 2040.
    Scand J Rheumatol. 2024 Feb 15:1-12. doi: 10.1080/03009742.2024.2312693.
    >> Share

    January 2024
  46. HOUGE IS, Hoff M, Videm V
    Self-determined motivation and physical activity in patients with rheumatoid arthritis: a cross-sectional study.
    Scand J Rheumatol. 2024 Jan 26:1-9. doi: 10.1080/03009742.2023.2300576.
    >> Share

  47. YOO WH, Ha GW, Kim KM, Choi Y, et al
    When treatment takes a turn: tocilizumab-induced bowel perforation in a patient with COVID-19-afflicted rheumatoid arthritis.
    Scand J Rheumatol. 2024 Jan 10:1-3. doi: 10.1080/03009742.2023.2294580.
    >> Share

  48. ROGIND SS, Hetland ML
    Delayed identification of disseminated infection in a patient with rheumatoid arthritis and septic arthritis: a case report.
    Scand J Rheumatol. 2024;53:72-73.
    >> Share

    December 2023
  49. MICHITSUJI T, Fukui S, Morimoto S, Endo Y, et al
    Clinical and ultrasound features of difficult-to-treat rheumatoid arthritis: A multicenter RA ultrasound cohort study.
    Scand J Rheumatol. 2023 Dec 12:1-7. doi: 10.1080/03009742.2023.2277542.
    >> Share

    November 2023
  50. KOMAI T, Sawada T, Tsuchiya H, Harada H, et al
    Resolution of exacerbated rheumatoid arthritis-associated interstitial lung disease under baricitinib treatment.
    Scand J Rheumatol. 2023 Nov 30:1-3. doi: 10.1080/03009742.2023.2274707.
    >> Share

  51. VAN WISSEN M, Straathof B, Vliet Vlieland T, van den Ende C, et al
    Construct validity of the PROMIS PF-10 in patients with inflammatory rheumatic diseases and severe limitations in physical functioning.
    Scand J Rheumatol. 2023;52:645-653.
    >> Share

  52. ZENG M, Issotina Zibrila A, Li X, Liu X, et al
    Pyridostigmine ameliorates pristane-induced arthritis symptoms in Dark Agouti rats.
    Scand J Rheumatol. 2023;52:627-636.
    >> Share

    October 2023
  53. BELAU MH, Flasskamp F, Becher H, Hajek A, et al
    Physical activity in adults with and without rheumatoid arthritis: cross-sectional results from the Survey of Health, Ageing and Retirement in Europe (SHARE).
    Scand J Rheumatol. 2023 Oct 31:1-6. doi: 10.1080/03009742.2023.2269672.
    >> Share

    September 2023
  54. ZHANG Y, Zhu F, Liu C, Wang M, et al
    A case report of Sjogren's syndrome complicated with immune-mediated necrotizing myopathy.
    Scand J Rheumatol. 2023;52:580-583.
    >> Share

  55. UHRENHOLT L, Christensen R, Dreyer L, Hauge EM, et al
    Disease activity-guided tapering of biologics in patients with inflammatory arthritis: a pragmatic, randomized, open-label, equivalence trial.
    Scand J Rheumatol. 2023;52:481-492.
    >> Share

  56. PFEIFFER-JENSEN M, Liao D, Tarp U, Deleuran B, et al
    Reduced prescription of TNF-inhibitors in chronic arthritis based on therapeutic drug monitoring: A randomized controlled trial.
    Scand J Rheumatol. 2023;52:468-480.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016